Profile_bird

Hey there! worldpharmanews is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving worldpharmanews's tweets.

Already using Twitter
from your phone? Click here.

worldpharmanews

  1. Boehringer Ingelheim and GlaxoSmithKline back EFA's call for urgent improvements in care for people with lung d.. http://bit.ly/3KYGF4 4:57 PM Nov 19th from twitterfeed
  2. 85% of Online Europeans Use the Internet for Health Information http://bit.ly/2oAQel 4:57 PM Nov 19th from twitterfeed
  3. 85% of Online Europeans Use the Internet for Health Information http://bit.ly/48JCRk 4:57 PM Nov 19th from twitterfeed
  4. FDA Advisory Committee Finds Data Support SPIRIVA® HandiHaler® http://bit.ly/1zzpn9 4:56 PM Nov 19th from twitterfeed
  5. AstraZeneca Submits US New Drug Application for Brilinta (Ticagrelor) http://bit.ly/1iN4hN 2:46 AM Nov 19th from twitterfeed
  6. First DataBank partners with unique medication management provider http://bit.ly/3COyCb 3:47 PM Nov 18th from twitterfeed
  7. British Innovation Shines at the iawards http://bit.ly/3MHnLC 3:47 PM Nov 18th from twitterfeed
  8. GSK and Nabi announce agreement for NicVAX®, a vaccine for nicotine addiction http://bit.ly/hflam 3:47 PM Nov 18th from twitterfeed
  9. Pfizer Submits New Pediatric Data For Lipitor® (Atorvastatin) To The European Medicines Agency (EMEA) http://bit.ly/1qGOGi 5:47 AM Nov 18th from twitterfeed
  10. Study Meets Primary Endpoint with 25 Percent LDL Reduction in Very High-Risk Patient Population http://bit.ly/sSnDH 5:52 PM Nov 17th from twitterfeed
  11. Lower doses of antigen may suffice to generate a protective immune response against A(H1N1) http://bit.ly/13JceP 5:52 PM Nov 17th from twitterfeed
  12. Study Meets Primary Endpoint with 25 Percent LDL Reduction in Very High-Risk Patient Population http://bit.ly/3mQpWf 3:55 PM Nov 17th from twitterfeed
  13. Abbott Announces Positive Three-Year Data on Its Fully Bioabsorbable Stent Technology http://bit.ly/3GGhrW 5:41 PM Nov 16th from twitterfeed
  14. BRILINTA Demonstrated Greater Efficacy Over Clopidogrel in the Most Urgent Clinical Setting http://bit.ly/23kHRw 5:41 PM Nov 16th from twitterfeed
  15. Researchers follow spread of HIV between cells http://bit.ly/2JcXx4 3:45 PM Nov 16th from twitterfeed
  16. Sanofi-aventis and Regeneron expand strategic Antibody Collaboration http://bit.ly/4duKgb 5:41 PM Nov 15th from twitterfeed
  17. Novartis launches Prevacid® 24 HR over-the-counter http://bit.ly/2Us6bO 5:41 PM Nov 15th from twitterfeed
  18. Parliament urges joint EU action on neurodegenerative diseases http://bit.ly/g7azp 3:45 PM Nov 15th from twitterfeed
  19. EFSD/Novo Nordisk partnership for diabetes research in Europe http://bit.ly/4hyRfp 5:45 PM Nov 12th from twitterfeed
  20. Nycomed reports continued satisfactory performance in the third quarter 2009 http://bit.ly/1dZu57 5:45 PM Nov 12th from twitterfeed